Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/27/2005US6949694 Genetic control of flowering in plants and cloning and expression of genes involved therein, in particular, cloning and expression of FY gene of Arabidopsis thaliana and manipulation and use of these genes in plants
09/27/2005US6949693 Promoters for gene expression in caryopses of plants
09/27/2005US6949692 Detection of genetic position of preferential mutation in rodents; obtain rodent, mate, monitor offspring for preferential phenotypes, mate offspring, monitor expression of mutant phenotypes
09/27/2005US6949691 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
09/27/2005US6949659 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins
09/27/2005US6949635 use with DNA polymerases that are thermostable or which contain an altered dNMP binding site
09/27/2005US6949634 Kit for gneration of preferential complmentary nucleotide sequences
09/27/2005US6949633 Primers useful for sizing nucleic acids
09/27/2005US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
09/27/2005US6949627 a purified polyclonal or monoclonal antibody which recognizes an epitope of a surface protein of a merozoite of Plasmodium falciparum; capable of inducing a resistance to the parasite so it can be used as a vaccine
09/27/2005US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor
09/27/2005US6949623 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells
09/27/2005US6949520 Methods related to immunostimulatory nucleic acid-induced interferon
09/27/2005US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine
09/27/2005US6949506 Relaxin-like factor and methods and uses thereof
09/27/2005US6949383 Mutagenesis method
09/27/2005US6949381 Immortalized human skin cell lines and novel serum-free medium useful for the production thereof
09/27/2005US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP)
09/27/2005US6949379 Aptamer-mediated regulation of gene expression
09/27/2005US6949376 Nucleic acid amplification reaction station for disposable test devices
09/27/2005US6949373 given amino acid sequence; telomerase motif; use as drug target for cancer
09/27/2005US6949372 Engineering intracellular sialylation pathways
09/27/2005US6949366 Complexing; purified polypeptide
09/27/2005US6949364 An isolated DNA encoding a protein, has testicular differentiation activity
09/27/2005US6949362 Rhodococcus cloning and expression vectors
09/27/2005US6949361 Polynucleotide
09/27/2005US6949360 DNA coding for human cell surface antigen
09/27/2005US6949357 Reagents and methods useful for detecting diseases of the urinary tract
09/27/2005US6949356 Methods for improving secondary metabolite production in fungi
09/27/2005US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase
09/27/2005US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF
09/27/2005US6949338 Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids
09/27/2005US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it
09/27/2005US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections
09/27/2005US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates
09/27/2005US6949242 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
09/27/2005US6949087 Apparatus with weeping tip and method of use
09/27/2005CA2391368C Genes and methods for manipulation of growth
09/27/2005CA2270289C Proteins with enhanced levels of essential amino acids
09/27/2005CA2250682C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
09/27/2005CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
09/27/2005CA2139670C Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
09/27/2005CA2099612C Monokine mig induced by ifn-gamma
09/27/2005CA2079814C Cationic lipids for intracellular delivery of biologically active molecules
09/22/2005WO2005088308A2 Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities
09/22/2005WO2005088288A1 Carbon nanotube biosensor
09/22/2005WO2005087950A1 Method of detecting nucleic acid using amplification on an array
09/22/2005WO2005087947A2 Bioengineered proteolytic enzymes with enhanced specificity for cytokine receptors
09/22/2005WO2005087942A1 Process for expresson of foreign genes in methylotrophic bacteria through chromosomal integration
09/22/2005WO2005087941A1 Process for producing l-fuculose and process for producing l-fucose
09/22/2005WO2005087936A1 Method of transferring gene into embryonic stem cell
09/22/2005WO2005087935A1 Methods for screening for genes and small molecules that activate mammalian receptor proteins
09/22/2005WO2005087934A2 Barley for production of flavor-stable beverage
09/22/2005WO2005087933A1 Thiol methyltransferase-based selection
09/22/2005WO2005087932A2 Vectors for directional cloning
09/22/2005WO2005087931A1 Modified oncolytic viruses
09/22/2005WO2005087930A1 Polynucleotides for the detection of escherichia coli o157
09/22/2005WO2005087929A1 Infectious aetiology of prostatic disease and methods to identify causative agents
09/22/2005WO2005087928A1 Proteins imparting boron-tolerance and genes thereof
09/22/2005WO2005087927A1 Method for preparation and purification or recombinant proteins
09/22/2005WO2005087926A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
09/22/2005WO2005087925A1 Recombinant gene, disease animal model and method of evaluating test substance
09/22/2005WO2005087924A1 Dna chip and method of extracting disease-associated genes
09/22/2005WO2005087923A1 A small synthetic rna, a method of preparing the same and uses thereof
09/22/2005WO2005087922A1 Altered expression in filamentous fungi
09/22/2005WO2005087911A1 Microbe culturing apparatus and utilizing the same, hydrogen production apparatus and fuel cell system
09/22/2005WO2005087810A2 Dimeric fusion proteins and materials and methods for producing them
09/22/2005WO2005087807A1 Vr1 receptors and uses thereof
09/22/2005WO2005087802A2 Process for producing polypeptides
09/22/2005WO2005087790A1 A nucleotide specific for o-antigen of escherichia coli o114 type
09/22/2005WO2005087784A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
09/22/2005WO2005087249A1 Protease inhibitor and preventives or remedies for diseases
09/22/2005WO2005086993A1 Method for preparing transgenic pepper using callus induction
09/22/2005WO2005086938A2 Artificial mutation controls for diagnostic testing
09/22/2005WO2005086934A2 Enriched cdna expression libraries and methods of making and using same
09/22/2005WO2005086922A2 Oncolytic adenovirus armed with therapeutic genes
09/22/2005WO2005086907A2 Biosynthetic gene cluster for ambruticins
09/22/2005WO2005086896A2 Delivery vectors for short interfering rna, micro-rna and antisense rna
09/22/2005WO2005086875A2 A humanized anti-cea t84.66 antibody and uses thereof
09/22/2005WO2005086835A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
09/22/2005WO2005086825A2 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
09/22/2005WO2005086813A2 Glutamine-rich maize seed protein and promoter
09/22/2005WO2005086794A2 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
09/22/2005WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery
09/22/2005WO2005086695A2 Intracellular interleukin-1 receptor antagonist and uses thereof
09/22/2005WO2005086670A2 Production of chemicals from lignocellulose, biomass or sugars
09/22/2005WO2005086667A2 High efficiency peptide production in plant cells
09/22/2005WO2005086654A2 Self-cleaving affinity tags and methods of use
09/22/2005WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
09/22/2005WO2005080418A3 Multimerised hiv fusion inhibitors
09/22/2005WO2005073384A3 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
09/22/2005WO2005070214A8 Peptides for inhibiting insects
09/22/2005WO2005069913A3 Expression of mammalian proteins in pseudomonas fluorescens
09/22/2005WO2005068498A3 Human therapeutic cells secreting nerve growth factor
09/22/2005WO2005058946A3 Methods for enhancing expression of recombinant proteins
09/22/2005WO2005056020B1 Nf-kb oligonucleotide decoy molecules
09/22/2005WO2005052143A3 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
09/22/2005WO2005044981A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/22/2005WO2005038018A8 Cloning of cytochrome p450 genes from nicotiana
09/22/2005WO2005038006A8 Chimeric metabotropic glutamate receptors and uses thereof